
-
Germany presses ahead with deportations to Afghanistan
-
Crews rescue 18 miners trapped in Colombia
-
McIlroy five back as Harman leads British Open
-
Lyles the showman ready to deliver 100m entertainment
-
EU targets Russian oil in tough new Ukraine war sanctions
-
Liverpool line up swoop for Frankfurt striker Ekitike: reports
-
Stocks up, dollar down tracking Trump moves and earnings
-
Three Sri Lankan elephants killed in blow to conservation efforts
-
Indie game studios battle for piece of Switch 2 success
-
Former Liverpool and Man Utd star Ince banned for drink-driving
-
Spain taming fire that belched smoke cloud over Madrid
-
Top Holy Land clerics visit Gaza after deadly church strike
-
Scotland end tour with seven-try thrashing of Samoa
-
Sharaa's pullout from Syria Druze heartland exposes shaky leadership
-
Trump team to seek release of Epstein documents
-
Wrexham chief wants playoff push after promotion to Championship
-
Snoop Dogg becomes co-owner of Championship club Swansea
-
Pakistan bans new hotel construction around tourist lakes
-
Trump's budget hacksaw leaves public broadcasting on precipice
-
New deep sea mining rules lack consensus despite US pressure
-
Stocks head for positive end to week, Tokyo struggles ahead of vote
-
North Korea bars foreign tourists from new seaside resort
-
Lions ignoring the noise ahead of Wallabies Test
-
CBS says Stephen Colbert's 'The Late Show' to end in May 2026
-
Lions block Wallabies flanker Samu from Pasifika team
-
Indian state blames cricket team for deadly stampede
-
Trump threatens to sue WSJ, Murdoch over story on alleged 2003 letter to Epstein
-
Serbian youth pumps up protest at last EXIT festival
-
US Congress approves $9 bn in Trump cuts to foreign aid, public media
-
Misbehaving monks: Sex scandal shakes Thai Buddhist faithful
-
Injury rules All Blacks wing Ioane out of third France Test
-
China mulls economy-boosting measures to counter 'severe situation'
-
Wallabies skipper Wilson concedes losing Valetini a massive blow
-
Asian markets on course to end week on a positive note
-
UK 'princes in the tower' murder probe clears Richard III
-
From Antarctica to Brussels, hunting climate clues in old ice
-
Springboks pick dynamic half-backs for final Championship warm-up
-
Jorge Martin returns to MotoGP racing at revamped Brno
-
Olympic champion Lyles to make 100m season debut at London Diamond League
-
Japan's SMEs ready to adapt to Trump tariffs
-
South Korea to end private adoptions after landmark probe
-
California to sue Trump govt over axed high-speed rail funds
-
Brazil's Lula calls Trump's tariff threat 'unacceptable blackmail'
-
In rural Canadian town, new risk of measles deepens vaccine tensions
-
What to know about Trump's effort to oust Fed Chair Powell
-
Trump threatens to sue WSJ over story on alleged 2003 letter to Epstein
-
Gulf Air orders 12 Boeing 787 Dreamliners
-
Japan rice prices double, raising pressure on PM
-
'A trap' - Asylum seekers arrested after attending US courts
-
Processa Pharmaceuticals and BullFrog AI Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Google AI tool predicts danger of genetic mutations
Researchers at Google DeepMind, the tech giant's artificial intelligence arm, on Tuesday introduced a tool that predicts whether genetic mutations are likely to cause harm, a breakthrough that could help research into rare diseases.
The findings are "another step in recognising the impact that AI is having in the natural sciences," said Pushmeet Kohli, vice president for research at Google DeepMind.
The tool focuses on so-called "missense" mutations, where a single letter of the genetic code is affected.
A typical human has 9,000 such mutations throughout their genome; they can be harmless or cause diseases such as cystic fibrosis or cancer, or damage brain development.
To date, four million of these mutations have been observed in humans, but only two percent of them have been classified, either as disease-causing or benign.
In all, there are 71 million such possible mutations. The Google DeepMind tool, called AlphaMissense, reviewed these mutations and was able to predict 89 percent of them, with 90 percent accuracy.
A score was assigned to each mutation, indicating the risk of it causing disease (otherwise referred to as pathogenic).
The result: 57 percent were classified as probably benign, and 32 percent as probably pathogenic -- the remainder being uncertain.
The database was made public and available to scientists, and an accompanying study was published on Tuesday in the journal Science.
AlphaMissense demonstrates "superior performance" than previously available tools, wrote experts Joseph Marsh and Sarah Teichmann in an article also published in Science.
"We should emphasize that the predictions were never really trained or never really intended to be used for clinical diagnosis alone," said Jun Cheng of Google DeepMind.
"However, we do think that our predictions can potentially be helpful to increase the diagnosed rate of rare disease, and also potentially to help us find new disease-causing genes," Cheng added.
Indirectly, this could lead to the development of new treatments, the researchers said.
The tool was trained on the DNA of humans and closely-related primates, enabling it to recognize which genetic mutations are widespread.
Cheng said the training allowed the tool to input "millions of protein sequences and learns what a regular protein sequence looks like."
It then could identify a mutation and its potential for harm.
Cheng compared the process to learning a language.
"If we substitute a word from an English sentence, a person that is familiar with English can immediately see whether this word substitution will change the meaning of the sentence or not."
C.Garcia--AMWN